Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers

NCT05588531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Group 1:YK-1169
DRUG: Group 2:YK-1169/Placebo Injection
DRUG: Group 3:YK-1169/Placebo
DRUG: Group 4:YK-1169/Placebo
DRUG: Group 5:YK-1169/Placebo Injection
DRUG: Group 6:YK-1169/Cefepime hydrochloride for injection/Avibactam for injection

Sponsor

Nanjing Yoko Biomedical Co., Ltd.